Strategic Initiative
Slingshot members are tracking this corporate initiative:
Depomed Announces Closing of Acquisition of U.S. Rights to NUCYNTA (tapentadol), NUCYNTA ER (tapentadol) extended release tablets and NUCYNTA (tapentadol) oral solution from Janssen Pharmaceuticals, Inc. for $1.05 billion
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Apr 02, 2015 Projected Implementation: Q3, 2015 Relevance Tracked Until: Q4, 2015
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Nucynta, Tapentadol
